e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Quantitative multivolume proton-magnetic resonance imaging in patients with cystic fibrosis lung disease: comparison with clinical indicators
Francesca Pennati, Caterina Salito, Irene Borzani, Giulia Cervellin, Simone Gambazza, Riccardo Guarise, Maria Chiara Russo, Carla Colombo, Andrea Aliverti
Source:
Eur Respir J, 53 (5) 1702020; 10.1183/13993003.02020-2017
Journal Issue:
May
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Francesca Pennati, Caterina Salito, Irene Borzani, Giulia Cervellin, Simone Gambazza, Riccardo Guarise, Maria Chiara Russo, Carla Colombo, Andrea Aliverti. Quantitative multivolume proton-magnetic resonance imaging in patients with cystic fibrosis lung disease: comparison with clinical indicators. Eur Respir J, 53 (5) 1702020; 10.1183/13993003.02020-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Multivolume magnetic resonance imaging (1H-MRI) for the longitudinal assessment of cystic fibrosis (CF) lung disease: comparison with spirometry
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020
Assessment of chest magnetic resonance imaging in non-cystic fibrosis chronic lung disease: comparison to high-resolution computed tomography and correlation with clinical and pulmonary function data
Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease
Year: 2009
Novel magnetic resonance technique for functional imaging of cystic fibrosis lung disease
Source: Eur Respir J, 50 (6) 1701464; 10.1183/13993003.01464-2017
Year: 2017
Assessment of a new magnetic resonance imaging (MRI)-scoring- system for pulmonary changes in patients with cystic fibrosis (CF) – comparison with clinical parameters and high resolution computed tomography (HRCT)
Source: Annual Congress 2006 - New modalities and application in imaging of the chest
Year: 2006
Functional magnetic resonance imaging and lung function tests in cystic fibrosis
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017
Magnetic resonance imaging (MRI) as a non-invasive, radiation-free imaging modality to study the onset and progression of lung disease in infants and young children with cystic fibrosis
Source: Annual Congress 2011 - Cystic fibrosis: detection and monitoring of early lung disease
Year: 2011
Role of chest magnetic resonance imaging (MRI) in the assessment and follow up of patients with cystic fibrosis (CF)
Source: Annual Congress 2010 - Infection, inflammation and destruction
Year: 2010
Quantitative multivolume magnetic resonance imaging (1H-MRI) in patients with cystic fibrosis (CF) lung disease:comparison with FEV1 and lung clearance index (LCI)
Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers
Year: 2017
Detection and monitoring of lung inflammation in cystic fibrosis during respiratory tract exacerbation using diffusion-weighted magnetic resonance imaging
Source: Eur Respir J, 50 (1) 1601437; 10.1183/13993003.01437-2016
Year: 2017
Comparison of 1H MRI and 3He MRI ventilation images in patients with cystic fibrosis and patients with lung cancer
Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities
Year: 2018
Hyperpolarised
129
Xe magnetic resonance imaging to monitor treatment response in children with cystic fibrosis
Source: Eur Respir J, 53 (5) 1802188; 10.1183/13993003.02188-2018
Year: 2019
Evaluation of the peripheral airway microstructure in children with cystic fibrosis (CF) using
3
He magnetic resonance imaging
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new therapies and detection of early lung disease
Year: 2012
Gadofosveset-enhanced lung magnetic resonance imaging to detect ongoing vascular leak in pulmonary fibrosis
Source: Eur Respir J, 51 (5) 1800171; 10.1183/13993003.00171-2018
Year: 2018
Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial
Source: Eur Respir J 2009; 34: 1311-1321
Year: 2009
Magnetic resonance imaging (MRI) of the lung as a tool for the non-invasive evaluation of drugs in rat models of airways diseases
Source: Annual Congress 2005 - New modalities and application in lung and airway imaging
Year: 2005
Comparison of in-vivo lung morphometry models from multiple b-value diffusion-weighted MRI in healthy controls, IPF and COPD patients
Source: International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses
Year: 2017
Non-contrast-enhanced assessment of lung perfusion in CF patients during respiratory tract exacerbation using Fourier decomposition magnetic resonance imaging (FDMRI)
Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI
Year: 2020
Imaging of cystic fibrosis: functional MRI
versus
conventional CT
Source: Annual Congress 2007 - Imaging of inflammatory airway diseases
Year: 2007
The use of chest magnetic resonance imaging in interstitial lung disease: a systematic review
Source: Eur Respir Rev, 27 (150) 180062; 10.1183/16000617.0062-2018
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept